Trial Details

RECRUITING
Basic Information
Clinical ID c989
Identifier NCT05725876
Trial Title Quantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate the Drug Distribution Throughout Inflamed Tissue in Crohn's Disease and Psoriasis.
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Psoriasis|Crohn Disease
Interventions DRUG: Ustekinumab
Participant Information
Sponsor University Medical Center Groningen
City Groningen
Country/Region Netherlands
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2025-01-06
Primary Completion Date 2026-07-01
Completion Date 2027-01-06